| 1 |
What is the primary function of AI in the medical imaging industry?
|
To improve diagnostic accuracy and patient outcomes |
|
the AI is use to support clinical decision and workflow |
Understanding the factors influencing acceptability of AI in medical imaging domains among healthcare professionals: A scoping review from ScienceDirect |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
Which of the following is a key benefit of AI in radiology noted in the article?
|
Acts as a second medical opinion |
|
the AI analyze the patient result and produce a medical opinion to compare with the radiologist opinion |
Understanding the factors influencing acceptability of AI in medical imaging domains among healthcare professionals: A scoping review from ScienceDirect . section 2 methodology |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
What does AI literacy refer to according to the article?
|
Understanding and knowledge of AI technology |
|
the study of AI as written in the article |
Understanding the factors influencing acceptability of AI in medical imaging domains among healthcare professionals: A scoping review from ScienceDirect . Abstract Result |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
Which factor is NOT listed as influencing the acceptability of AI among healthcare professionals?
|
The color of the AI machines |
|
the color doesn't influence the acceptability |
Understanding the factors influencing acceptability of AI in medical imaging domains among healthcare professionals: A scoping review from ScienceDirect . section 3.8. Factors influencing healthcare professional acceptability of AI in medical imaging domains |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
What role does social influence play in AI acceptability in healthcare according to the article?
|
Shapes how AI is marketed |
|
social influence will control how AI is displayed to the public whether positively or negatively |
Understanding the factors influencing acceptability of AI in medical imaging domains among healthcare professionals: A scoping review from ScienceDirect . section 3.8. Factors influencing healthcare professional acceptability of AI in medical imaging domains |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
What is a perceived threat regarding AI usage in healthcare settings?
|
Concerns about replacing healthcare professionals |
|
healthcare professional are concern that it will take their jobs |
Understanding the factors influencing acceptability of AI in medical imaging domains among healthcare professionals: A scoping review from ScienceDirect . section 3.8. Factors influencing healthcare professional acceptability of AI in medical imaging domains |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
According to the article, what is essential for increasing AI acceptability among medical professionals?
|
Designing human-centred AI systems |
|
with the AI being Human-Centred the concerns about jobs and false diagnostic will mostly be solve. |
Understanding the factors influencing acceptability of AI in medical imaging domains among healthcare professionals: A scoping review from ScienceDirect . section 4.8. Future work and direction |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
What does the 'system usage' category of AI acceptability factors include according to the article?
|
Factors like value proposition and integration with workflows |
|
it contain mostly about the aspect about working and efficiency |
Understanding the factors influencing acceptability of AI in medical imaging domains among healthcare professionals: A scoping review from ScienceDirect . section 3.8. Factors influencing healthcare professional acceptability of AI in medical imaging domains |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
How does ethicality impact AI acceptability among healthcare professionals?
|
Affects views on AI based on compatibility with professional values |
|
ethicality focus on medical profession and patient data privacy |
Understanding the factors influencing acceptability of AI in medical imaging domains among healthcare professionals: A scoping review from ScienceDirect . section 3.8. Factors influencing healthcare professional acceptability of AI in medical imaging domains |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
What methodological approach did the article emphasize for future AI acceptability studies?
|
Considering user experience and system integration deeply |
|
the user trust and essential to appropriately integrate AI in the the medical network |
Understanding the factors influencing acceptability of AI in medical imaging domains among healthcare professionals: A scoping review from ScienceDirect . section 2. Methodology |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
What is the primary objective of using human embryonic stem cells in treating Parkinson’s disease?
|
To replace lost dopamine neurons. |
|
in hope of replacing the DA neuron stem cell is considered to be a perfect replacement |
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson’s disease, STEM-PD Introduction |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
Which animal was used to test the STEM-PD product for safety and efficacy?
|
Rats |
|
rats was use to test for adverse effect and tumor formation |
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson’s disease, STEM-PD
Manufacturing and quality control of STEM-PD |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
What was the duration of the preclinical safety study in rats mentioned in the article?
|
9 months |
|
the time was mention in the study highlight |
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson’s disease, STEM-PD . Hight light |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
What is the name of the clinical trial phase mentioned for STEM-PD?
|
Phase I/IIa |
|
tested on a single arm on a human |
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson’s disease, STEM-PD . Introduction |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
How is the STEM-PD product manufactured?
|
Under GMP-compliant conditions |
|
using MCB manufactured from GMP grade line |
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson’s disease, STEM-PD .Manufacturing and quality control of STEM-PD |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
According to the article, what confirmed the safety of the STEM-PD product in rats?
|
There were no adverse effects or tumor formation. |
|
no adverse effect were found including no tumor formation |
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson’s disease, STEM-PD . Hight light |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
What key finding was noted in the efficacy study of STEM-PD in rats?
|
Transplanted cells reversed motor deficits in rats. |
|
the stem cell reverse the amphetamine effect on the rat |
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson’s disease, STEM-PD . STEM-PD grafts are rich in DA neurons, innervate the host brain, and reverse amphetamine-induced rotations in rats |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
What specific markers were used to assess the purity of the STEM-PD batch?
|
FOXA2 and OTX2 |
|
written in the invivo and batch to batch comparison |
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson’s disease, STEM-PD . STEM-PD shows robust and reproducible in vivo efficacy in batch-to-batch comparison |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
What role do growth factors like FGF8b and SHH play in the manufacturing process of STEM-PD?
|
They are used in cell patterning for specific neural fates. |
|
it tell the cell what shape and how they should arrange themself |
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson’s disease, STEM-PD . Manufacturing and quality control of STEM-PD |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
What was a key outcome measured in the preclinical trials for efficacy in rats?
|
Recovery of motor function |
|
the rats regain the motor function that was lost from amphetamine-induced rotation |
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson’s disease, STEM-PD . STEM-PD grafts are rich in DA neurons, innervate the host brain, and reverse amphetamine-induced rotations in rats |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|